Petco Health and Wellness 주식 (NASDAQ: WOOF)

에 대한 최신 뉴스 Petco Health and Wellness (NASDAQ:WOOF) 주식

Petco Health and Wellness

Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.

News

Movers

$BTC

AVGO

BNTX

CHWY

EXAS

FSLR

MSTR

ORCL

ROKU

SMMT

WOOF

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 서밋 테라퓨틱스(NASDAQ:SMMT)의 주식은 회사가 $2억 3,500만의 순수익을 올렸다고 발표한 후 98.32% 급등했다.

츄이, 브로드컴 및 ARM은 지난주 최고 성과를 보여준 10개 대형주 중 일부 (9월 8일-9월 14일)

After-Hours Center

애완동물 사료 및 관련 제품을 판매하는 미국의 온라인 소매업체인 츄이(NYSE:CHWY)의 주가는 펫코 헬스 앤드 웰니스(NASDAQ:WOOF)의 2분기 재무 결과에 따라 수요일 급등했다.

수요일 애완동물 용품 소매업체인 츄이의 주식 급등: 알아야 할 사항

Trading Ideas

BARK

FRPT

LMND

PETS

TRUP

투자자 라이언 코헨(Ryan Cohen)은 애완동물 용품 및 애완동물 건강 제품의 성장 추세에 맞춰 2011년에 츄이(NYSE:CHWY)를 설립했다. 새로운 데이터에 따르면 코헨은 애완동물 용품 및 애완동물 보험에 대한 지출이 크게 증가하는 등 이러한 추세에 초기에 대처했을 수 있었다. 일부는 벌써 그를 전설적인 투자자(GOAT, greatest of all time)들 중 한 명으로 보고 있다. 

라이언 코헨은 GOAT? 츄이의 창립은 애완동물 용품 분야에서 엄청난 추세를 미리 예상

Petco Health and Wellness Company, Inc. - Class A Common Stock

Petco Health and Wellness Co Inc

Morgan Stanley analyst Simeon Gutman maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and lowers the price target from $6 to $5.

Price Target

Analyst Ratings

Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Lowers Price Target to $5

RBC Capital analyst Steven Shemesh reiterates Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and maintains $6 price target.

Reiteration

RBC Capital Reiterates Outperform on Petco Health and Wellness, Maintains $6 Price Target

<h3>Gainers</h3>
<ul>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) stock increased by 38.6% to $3.19 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) stock moved upwards by 22.44% to $6.0. The market value of their outstanding shares is at $1.6 billion. As per the news, the Q3 earnings report came out yesterday. </li>
<li>Color Star Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADD#NASDAQ">ADD</a>) shares rose 18.75% to $4.59. The market value of their outstanding shares is at $2.8 million. </li>
<li>American Outdoor Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AOUT#NASDAQ">AOUT</a>) stock moved upwards by 12.01% to $12.21. The market value of their outstanding shares is at $156.7 million. The company's, Q2 earnings came out yesterday. </li>
<li>Lululemon Athletica (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LULU#NASDAQ">LULU</a>) shares moved upwards by 10.19% to $379.97. The market value of their outstanding shares is at $46.6 billion. The company's, Q3 earnings came out yesterday. </li>
<li>Zumiez (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZUMZ#NASDAQ">ZUMZ</a>) stock increased by 9.17% to $22.01. The company's market cap stands at $421.3 million. As per the news, the Q3 earnings report came out yesterday. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Smith &amp; Wesson Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) stock declined by 16.7% to $11.35 during Friday's pre-market session. The company's market cap stands at $509.0 million. As per the news, the Q2 earnings report came out yesterday. </li>
<li>Latham Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWIM#NASDAQ">SWIM</a>) stock fell 15.89% to $5.4. The market value of their outstanding shares is at $624.3 million. </li>
<li>United Homes Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UHG#NASDAQ">UHG</a>) stock fell 15.74% to $5.14. The company's market cap stands at $248.8 million. </li>
<li>EpicQuest Education Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EEIQ#NASDAQ">EEIQ</a>) shares decreased by 8.92% to $0.92. The company's market cap stands at $11.9 million. </li>
<li>GigaCloud Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GCT#NASDAQ">GCT</a>) shares declined by 8.7% to $22.15. The market value of their outstanding shares is at $907.5 million. </li>
<li>Shoe Carnival (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCVL#NASDAQ">SCVL</a>) shares fell 8.23% to $30.0. The market value of their outstanding shares is at $814.7 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AOUT

EEIQ

JFBR

LULU

SCVL

SWBI

SWIM

ZUMZ

12 Consumer Discretionary Stocks Moving In Friday's Pre-Market Session

Petco Health and Wellness Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported better-than-expected results for its <a href="https://www.benzinga.com/quote/WOOF/earnings">third quarter on Thursday.</a>
The company posted a quarterly loss of 1 cents per share versus market estimates of a loss of 4 cents per share. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion.
&#8220;Our third quarter results demonstrate the meaningful progress we&#8217;re making to strengthen our retail fundamentals to drive sustainable, profitable growth,&#8221; said Joel Anderson, Petco&#8217;s Chief Executive Officer. &#8220;While there is more work to do, our improving results increase our conviction that we are on the right path to position Petco to win long-term. Our entire organization is focused on driving profitability and free cash flow, and I&#8217;m confident we&#8217;re set up for a solid finish to 2024.&#8221;
Petco Health shares gained 16.9% to trade at $5.73 on Friday.
These analysts made changes to their price targets on Petco Health following earnings announcement.
<ul>
<li>Wells Fargo analyst Zachary Fadem maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $5.</li>
<li>RBC Capital analyst Steven Shemesh maintained the stock with an Outperform and boosted the price target from $5 to $6.</li>
<li>Morgan Stanley analyst Simeon Gutman maintained Petco Health and Wellness with an Equal-Weight and raised the price target from $3 to $6.</li>
<li>Wedbush analyst Seth Basham maintained Petco Health and Wellness with an Outperform and boosted the price target from $5.5 to $6.</li>
</ul>
Considering buying WOOF stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="567" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png" alt="" class="wp-image-681107" style="width:571px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-1024x567.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-300x166.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454-768x426.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/06130514/Screenshot-2024-12-06-233454.png 1173w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/12/42364367/how-to-earn-500-a-month-from-oracle-stock-ahead-of-q2-earnings">How To Earn $500 A Month From Oracle Stock Ahead Of Q2 Earnings</a></li>
</ul>

Earnings

Markets

These Analysts Increase Their Forecasts On Petco Health and Wellness After Strong Q3 Results

Wedbush analyst Seth Basham maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5.5 to $6.

Wedbush Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

Morgan Stanley analyst Simeon Gutman maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $6.

Morgan Stanley Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $6

RBC Capital analyst Steven Shemesh maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Outperform and raises the price target from $5 to $6.

RBC Capital Maintains Outperform on Petco Health and Wellness, Raises Price Target to $6

WIIM

Petco Health shares are trading higher after Wells Fargo raised its price target on the stock from $3 to $5.

7 analysts have expressed a variety of opinions on Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) over the past quarter, offering a diverse set of opinions from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.36, a high estimate of $5.50, and a low estimate of $3.00. Witnessing a positive shift, the current average has risen by 10.1% from the previous average price target of $3.96.
<img src="https://www.benzinga.com/files/images/story/2024/1733497339_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Petco Health and Wellness among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$5.00</td>
<td>$3.00</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Raises</td>
<td>Outperform</td>
<td>$5.50</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Zaccone</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Neutral</td>
<td>$4.50</td>
<td>$4.00</td>
</tr>
<tr>
<td>Kate McShane</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$4.00</td>
<td>$5.00</td>
</tr>
<tr>
<td>Steven Shemesh</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$3.50</td>
<td>$3.00</td>
</tr>
<tr>
<td>Zachary Fadem</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$3.00</td>
<td>$2.75</td>
</tr>
<tr>
<td>Seth Basham</td>
<td>Wedbush</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$5.00</td>
<td>$5.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Petco Health and Wellness. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Petco Health and Wellness compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Petco Health and Wellness's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Petco Health and Wellness's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WOOF/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Petco Health and Wellness analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Get to Know Petco Health and Wellness Better</h2>
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
<h3>Financial Milestones: Petco Health and Wellness's Journey</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Petco Health and Wellness's revenue growth over a period of 3 months has faced challenges. As of 31 July, 2024, the company experienced a revenue decline of approximately -0.46%. This indicates a decrease in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Consumer Discretionary sector.
Net Margin: Petco Health and Wellness's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -1.63%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Petco Health and Wellness's ROE stands out, surpassing industry averages. With an impressive ROE of -2.16%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.47%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a high debt-to-equity ratio of 2.64, Petco Health and Wellness faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>Analyst Ratings: What Are They?</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Ratings For Petco Health and Wellness

Wells Fargo analyst Zachary Fadem maintains Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) with a Equal-Weight and raises the price target from $3 to $5.

Wells Fargo Maintains Equal-Weight on Petco Health and Wellness, Raises Price Target to $5

The earnings results for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Overview of Past Earnings</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness: Q3 Earnings Insights

Petco Health and Wellness shares are trading higher after the company announced better-than-expected Q3 financial results.

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Past Earnings Performance</h3>
The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Summary: Petco Health and Wellness Q3

The Q3 earnings report for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) was released on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the latest announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Earnings History Overview</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Q3 Earnings Assessment

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) announced its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.
Here's a breakdown of the earnings report.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Analysis of Past Earnings</h3>
Last quarter the company missed on EPS by $0.0 which was followed by a 33.0% increase in the share price the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Breakdown: Petco Health and Wellness Q3

The earnings results for Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) for Q3 were made public on Thursday, December 5, 2024 at 04:02 PM.
Here's a comprehensive overview of the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Performance in Previous Earnings</h3>
The company missed on EPS by $0.0 in the previous quarter, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Guidance</h3>
Petco Health and Wellness management provided guidance for Q4 2024, expecting earnings between $0.0 and $0.02 per share.
To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Earnings Review: Q3 Summary

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported its Q3 earnings results on Thursday, December 5, 2024 at 04:02 PM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Overview of Past Earnings</h3>
During the previous quarter, the company missed on EPS by $0.0, leading to a 33.0% increase share price change the next day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights into Petco Health and Wellness Q3 Earnings

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) just disclosed its Q3 earnings on Thursday, December 5, 2024 at 04:02 PM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Petco Health and Wellness beat estimated earnings by 50.0%, reporting an EPS of $-0.02 versus an estimate of $-0.04.
Revenue was up $17.00 million from the same period last year.
<h3>Earnings History Overview</h3>
The company missed on EPS by $0.0 in the last quarter, resulting in a 33.0% increase share price change the following day.
Here's a look at Petco Health and Wellness's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.02</td>
<td>-0.07</td>
<td>0.02</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.02</td>
<td>-0.04</td>
<td>0.02</td>
<td>-0.05</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>1.52B</td>
<td>1.51B</td>
<td>1.62B</td>
<td>1.51B</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>1.52B</td>
<td>1.53B</td>
<td>1.67B</td>
<td>1.49B</td>
</tr>
</tbody>
</table>

To track all earnings releases for Petco Health and Wellness <a href="https://www.benzinga.com/quote/WOOF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Petco Health and Wellness Earnings Report: Q3 Overview

Fiscal Q4 2024 Outlook
The company is providing Q4 guidance for revenue, Adjusted EBITDA, and Adjusted EPS, in addition to full year interest expense and capital expenditure expectations.
For Fiscal Q4 2024, the company expects:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric&#x2A;</td>
<td colspan="1" rowspan="1">
FQ4 2024
Guidance
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net Revenue</td>
<td colspan="1" rowspan="1">~ $1.55 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EBITDA</td>
<td colspan="1" rowspan="1">Between $90 million and $95 million, including a minimum of $10 million in third party consulting fees associated with our transformation effort</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Adjusted EPS</td>
<td colspan="1" rowspan="1">Between $0.00 and $0.02</td>
</tr>
</tbody>
</table>
</figure>
For Fiscal 2024 (a 52-week year), the company expects the following:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">Metric&#x2A;</td>
<td colspan="1" rowspan="1">
2024
Guidance, YoY
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Net interest expense</td>
<td colspan="1" rowspan="1">~$140 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">Capital Expenditures</td>
<td colspan="1" rowspan="1">~$130 million</td>
</tr>
</tbody>
</table>
</figure>
&#x2A;Assumptions in the guidance include that economic conditions, currency rates and the tax and regulatory landscape remain generally consistent. For fiscal 2024, our guidance anticipates a 26 percent tax rate, and 273 million weighted average diluted share count. Adjusted EBITDA and Adjusted EPS are non-GAAP financial measures and have not been reconciled to the most comparable GAAP outlook because it is not possible to do so without unreasonable efforts due to the uncertainty and potential variability of reconciling items, which are dependent on future events and often outside of management's control and which could be significant. Because such items cannot be reasonably predicted with the level of precision required, we are unable to provide outlook for the comparable GAAP measures. Forward-looking estimates of Adjusted EBITDA and Adjusted EPS are made in a manner consistent with the relevant definitions and assumptions noted herein and in our filings with the Securities and Exchange Commission.

Guidance

Petco Health and Wellness Company Sees Q4 Adj EPS $0.00-$0.02 Vs $0.04 Est.; Revenue ~$1.55B Vs $1.57B Est.

Petco Health and Wellness (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.04) by 50 percent. This is a 60 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $1.51 billion which beat the analyst consensus estimate of $1.50 billion by 0.76 percent. This is a 1.17 percent increase over sales of $1.49 billion the same period last year.

Earnings Beats

Petco Health and Wellness Q3 Adj $(0.02) Beats $(0.04) Estimate, Sales $1.51B Beat $1.50B Estimate

RBC Capital raised the firm's price target on Petco (WOOF) to $6 from $5 and keeps an Outperform rating on the shares. The company reported another...

Petco price target raised to $6 from $5 at RBC Capital

Evercore ISI raised the firm's price target on Petco (WOOF) to $6 from $5 and keeps an In Line rating on the shares. The company's Q3 results were ...

Petco price target raised to $6 from $5 at Evercore ISI

Evercore ISI analyst Oliver Wintermantel has maintained their neutral stance on WOOF stock, giving a Hold rating today. Oliver Wintermantel's ratin...

Petco's Mixed Performance: Strong Q3 with Growth in Veterinary Services Amid Ongoing Challenges

The Gabelli Pet Parents' Fund Q3 2024 Commentary

Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on Tesla (TSLA – Research Report), Petco Healt...

Analysts Have Conflicting Sentiments on These Consumer Cyclical Companies: Tesla (TSLA), Petco Health and Wellness Company (WOOF) and Mission Produce (AVO)

The retail market is attractive due to expanding demand across various sectors, increased consumer spending, technological advancements, and a favorable economic environment fostering growth opportunities, making innovative retail stocks like Petco Health and Wellness Company (WOOF), Chewy (CHWY), and Levi Strauss (LEVI), which are adapting to new consumer trends, worth considering. Read on... The retail sector is expanding with innovations in social commerce, AI, personalization, and automation, driving improved outcomes. Consumer spending has increased on goods like apparel and essentials, as well as pet care. In this favorable landscape, investors could consider innovative retail stocks like Petco Health and Wellness Company, Inc. (<a href="https://stocknews.com/stock/WOOF/">WOOF</a>), Chewy, Inc. (<a href="https://stocknews.com/stock/CHWY/">CHWY</a>), and Levi Strauss &amp; Co. (<a href="https://stocknews.com/stock/LEVI/">LEVI</a>).
The retail sector, adapting to new consumer trends, offers stable investment potential, as consumer goods companies typically see consistent demand. With the U.S. Federal Reserve cutting interest rates by <a href="https://www.reuters.com/markets/rates-bonds/view-fed-cuts-25-bp-scales-back-2025-easing-projections-2024-12-18/">25 basis points</a> to 4.3% - 4.5% in December and projecting two more cuts by the end of 2025, the favorable economic environment presents an opportune time to invest in the sector as demand rises.
Consequently, the consumer goods market is projected to reach $2.80 trillion in 2024, with an expected <a href="https://www.statista.com/outlook/io/manufacturing/consumer-goods/worldwide">CAGR of 1.2%</a> from 2024 to 2029. Notably, the ever-evolving trends of the apparel sector benefit the consumer goods industry by driving online sales growth, influencing digital innovation, and enhancing customer experiences through personalized services, especially during the holidays now.
Further, the retail sector benefits from increased pet ownership, which has fueled demand for pet products and services. Retail innovations like auto-ship subscriptions and discounts are boosting sales, while growing interest in high-quality, health-focused pet foods is reshaping the market. The pet services market is projected to grow at a <a href="https://www.globenewswire.com/news-release/2024/11/27/2988366/28124/en/Pet-Services-Market-Forecast-by-Pet-Services-Service-Delivery-Channel-and-Region-2025-2030.html">CAGR of 11.7%</a>, reaching $63.96 billion by 2030.
Considering these conducive trends, let's analyze the fundamental aspects of the three <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> picks, beginning with the third choice.
Stock #3: Petco Health and Wellness Company, Inc. (<a href="https://stocknews.com/stock/WOOF/">WOOF</a>)
WOOF operates as a health and wellness company, focusing on enhancing the lives of pets, pet parents, and its Petco partners in the United States, Mexico, and Puerto Rico. The company provides veterinary care, grooming, training, telehealth, Vital Care, and pet health insurance services, as well as veterinary services through Vetco mobile clinics.
In terms of the trailing-12-month <a href="https://www.investopedia.com/terms/a/assetturnover.asp">asset turnover ratio</a>, WOOF's 1.17x is 19% higher than the industry average of 0.99x.
In the third quarter that ended November 2, 2024, WOOF's total net sales grew 1.2% from the year-ago value to $1.51 billion. The company's gross profit came in at $575.76 million, up 4.6% year-over-year. Furthermore, its adjusted EBITDA rose 12.6% from the prior year's quarter to $81.24 million.
Analysts expect WOOF's revenue for the quarter ending April 30, 2025, to increase 2% year-over-year to $1.56 billion. It surpassed the consensus EPS estimates in each of the trailing four quarters. WOOF's stock has gained 100% over the past nine months to close the last trading session at $3.96.
WOOF's robust outlook is reflected in its <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a>. It has an overall rating of B, equating to a Buy in our proprietary rating system. The POWR Ratings assess stocks by 118 different factors, each with its own weighting.
It has a B grade for Growth and Quality. Within the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry, it is ranked #16 out of 55 stocks. To access WOOF's grades for Value, Momentum, Stability, and Sentiment, <a href="https://stocknews.com/stock/WOOF/">click here</a>.
Stock #2: Chewy, Inc. (<a href="https://stocknews.com/stock/CHWY/">CHWY</a>)
CHWY engages in the pure-play e-commerce business in the United States. It provides pet food, treats, pet supplies, pet medications, and other pet health products, as well as pet services for dogs, cats, fish, birds, small pets, horses, and reptiles through its retail websites and mobile applications.
In terms of the trailing-12-month Return on Common Equity, CHWY's 130.34% is considerably higher than the 11.03% industry average. Its 13.59% trailing-12-month Return on Total Assets is 245.2% higher than the 3.94% industry average. Additionally, its 3.88x trailing-12-month asset turnover ratio is 298.8% higher than the 0.99x industry average.
CHWY's net sales for the third quarter ended October 27, 2024, increased 4.8% year-over-year to $2.88 billion. The company's gross profit rose 7.9% compared to the prior-year quarter, reaching $843.87 million. Additionally, its adjusted net income and adjusted EPS increased 33.8% and 33.3%, respectively, from the year-ago values, to $84.92 million and $0.20.
For the quarter ending January 31, 2025, CHWY's EPS is expected to grow 10.4% year-over-year to $0.20. Its revenue for the same quarter is expected to rise 12.8% year-over-year to $3.19 billion. It surpassed the Street EPS estimates in three of the trailing four quarters. Over the past nine months, the stock has gained 90.1% to close the last trading session at $33.72.
CHWY's strong fundamentals are reflected in its POWR Ratings. It has an overall rating of B, equating to a Buy in our proprietary rating system.
It has a B grade for Quality. It is ranked #13 in the same industry. To see CHWY's Growth, Value, Momentum, Stability, and Sentiment ratings, <a href="https://stocknews.com/stock/CHWY/">click here</a>.
Stock #1: Levi Strauss &amp; Co. (<a href="https://stocknews.com/stock/LEVI/">LEVI</a>)
LEVI designs, markets, and sells apparel and related accessories for men, women, and children worldwide. The company offers jeans, casual and dress pants, activewear, tops, shorts, skirts, dresses, jumpsuits, shirts, sweaters, jackets, footwear, and related accessories under the Levi's, Dockers, Signature by Levi Strauss &amp; Co., Denizen, and Beyond Yoga brands.
On October 11, 2024, LEVI's Beyond Yoga launched Club Beyond, a weeklong pop-up in New York City featuring fitness classes, wellness workshops, exclusive retail, and customization experiences. The event aims to expand its customer base, deepen engagement, and highlight the brand's pillars: mind, body, and connection.
In terms of the trailing-12-month EBIT margin, LEVI's 9.36% is 16.5% higher than the 8.03% industry average. Likewise, its 9.98% trailing-12-month levered FCF margin is 124.1% higher than the 4.45% industry average. Furthermore, the stock's 8.82% trailing-12-month Return on Total Capital is 41.8% higher than the 6.22% industry average.
During the fiscal third quarter that ended August 25, 2024, LEVI's net revenues increased marginally year-over-year to $1.52 billion. Similarly, its operating income stood at $30.30 million. For the same period, the company's adjusted EBITDA rose 25.6% from the year-ago value to $225.30 million.
Street expects LEVI's EPS and revenue for the quarter ending November 30, 2024, to increase 9.2% and 5.2% year-over-year to $0.48 and $1.74 billion, respectively. It surpassed the Street EPS estimates in each of the trailing four quarters. LEVI's stock has gained 12.9% over the past year to close the last trading session at $17.39.
LEVI's solid prospects are reflected in its POWR Ratings. It has an overall rating of B, translating to a Buy in our proprietary rating system.
It has a B grade for Growth, Sentiment, and Quality. It is ranked #2 in the Consumer Goods industry. Beyond what we stated above, we also have given LEVI grades for Value, Momentum, and Stability. Get all the LEVI's ratings <a href="https://stocknews.com/stock/LEVI/">here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
CHWY shares were trading at $34.77 per share on Monday afternoon, up $1.05 (+3.11%). Year-to-date, CHWY has gained 47.14%, versus a 26.33% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/chwy-levi-woof-3-innovative-retail-stocks-adapting-to-new-consumer-trends/>3 Innovative Retail Stocks Adapting to New Consumer Trends</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Innovative Retail Stocks Adapting to New Consumer Trends

Petco: A Bone To Pick With High Debt For This Difficult Turnaround

Wedbush analyst Seth Basham maintained a Buy rating on Petco Health and Wellness Company (WOOF – Research Report) today and set a price target of $...

Wedbush Remains a Buy on Petco Health and Wellness Company (WOOF)

Morgan Stanley lowered the firm's price target on Petco (WOOF) to $5 from $6 and keeps an Equal Weight rating on the shares. In the hardline, broad...

Petco price target lowered to $5 from $6 at Morgan Stanley

LEVI

PAWZ

TSLA

Press Releases

Roaring Kitty Expands Horizons: Key Stocks to Watch as Influencer Shakes Up Market: CHWY, DYAI, WOOF, VTAK, INBS

Legal

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health and Wellness Company, Inc. - WOOF

Petco Health and Wellness Company, Inc. Investors: Company Investigated by the Portnoy Law Firm

Petco Names Joel D. Anderson as Chief Executive Officer

Petco Health + Wellness Company, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Petco Health and Wellness Company, Inc. to Host Second Quarter 2024 Earnings Conference Call on September 10, 2024

Petco Health + Wellness Company, Inc. Reports Second Quarter 2024 Earnings Results

Petco Health and Wellness Company, Inc. to Host Third Quarter 2024 Earnings Conference Call on December 5, 2024

Petco Names Joe Venezia Chief Revenue Officer

Petco Health + Wellness Company, Inc. Reports Third Quarter 2024 Earnings Results

DYAI

VTAK

Academy Sports and Outdoors, Inc. - Common Stock

Academy Sports

Build-A-Bear Workshop

Bath & Body Works

Barnes & Noble Education, Inc Common Stock

Barnes & Noble Education

Chewy

Dick's Sporting Goods

Envela

National Vision Holdings, Inc. - Common Stock

National Vision Holdings

Five Below

1-800-FLOWERS.COM, Inc. - Class A Common Stock

1-800-Flowers.com

Fitell

MarineMax

Leslies

PetMed Express

Sally Beauty Holdings, Inc. (Name to be changed from Sally Holdings, Inc.) Common Stock

Sally Beauty Holdings

Signet Jewelers

Sportsman's Warehouse Holdings, Inc. - Common Stock

Sportsman's Warehouse

Tokyo Lifestyle Co., Ltd. - American Depositary Shares

Tokyo Lifestyle

Tractor Supply

Ulta Beauty

Upbound Group

Winmark

Warby Parker

Morgan Stanley

RBC Capital

Wedbush

Wells Fargo

Citigroup

이들 10개 대형주는 지난주 최고의 성과를 거두었다. 그것들이 당신의 포트폴리오에 있나요?
1. 서밋 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/40833208" target="_blank" rel="noreferrer noopener">$2억 3,500만</a>의 순수익을 올렸다고 발표한 후 98.32% 급등했다.
2. 바이오엔텍 SE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTX#NASDAQ">BNTX</a>)의 주식은 GSK가 단순 포진 바이러스 백신 개발을 중단하자 모더나와 바이오엔텍와 같은 다른 경쟁자들에게 길을 열어주면서 지난주 31.77% 상승했다.
3. 앱러빈 코퍼레이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>)의 주식은 여러 애널리스트들이 <a href="https://www.benzinga.com/quote/app/analyst-ratings" target="_blank" rel="noreferrer noopener">목표 주가를 올린 후</a> 28.38% 상승했다.
4. 츄이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>)의 주식은 펫코 헬스 앤 웰니스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)의 <a href="https://www.benzinga.com//node/40822147" target="_blank" rel="noreferrer noopener">재무 결과 발표</a>에 동조하는 분위기 속에서 21.37% 상승했다.
5. 브로드컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>)의 주식은 일부 반도체 주식의 <a href="https://www.benzinga.com//node/40852990" target="_blank" rel="noreferrer noopener">반등</a>으로 인해 20.81% 상승했다.
6. Arm 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>)의 주식은 레이먼드 제임스(Raymond James)가 주식을 아웃퍼폼(Outperform) 등급으로 분석을 시작하고 <a href="https://www.benzinga.com/quote/arm/analyst-ratings" target="_blank" rel="noreferrer noopener">$160의 목표 주가</a>를 발표한 후 20.50% 상승했다.
7. 마이크로스트레티지(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>)의 주식은 회사가 18,300개의 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)을 구매했다고 발표한 후 18.74% 상승했다.
8. 킨로스 골드(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KGC#NYSE">KGC</a>)의 주식은 회사가 <a href="https://www.benzinga.com//node/40788842" target="_blank" rel="noreferrer noopener">그레이트 베어(</a><a href="https://www.benzinga.com//node/40788842" target="_blank" rel="noreferrer noopener" data-google-interstitial="false">Great Bear</a><a href="https://www.benzinga.com//node/40788842" target="_blank" rel="noreferrer noopener">) 프로젝트</a>에 대한 초기 경제 평가를 완료했다고 발표한 후 17.14% 상승했다.
9. 워너 브라더스 디스커버리(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>)의 주식은 최근 발표된 차터(Charter)와의 다년간 파트너십으로 인해 지난주 17.10% 상승했다. 이 파트너십은 선형 비디오와 스트리밍 서비스를 통합하여 비디오 번들의 유연성과 가치를 향상시킨다.
10. 버티브 홀딩스, LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRT#NYSE">VRT</a>)의 주식은 17.02% 상승했다.
이미지 출처: Chewy
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

애완동물 사료 및 관련 제품을 판매하는 미국의 온라인 소매업체인 츄이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>)의 주가는 펫코 헬스 앤드 웰니스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)의 2분기 재무 결과에 따라 수요일 급등했다.
분기별 매출 15억 2천만 달러를 기록한 펫코의 실적 보고서는 분석가 추정치를 충족했지만, 이 회사는 <a href="https://www.benzinga.com/news/earnings/24/09/40815911/chewy-just-overtook-the-20-day-moving-average" target="_blank" rel="noopener" data-google-interstitial="false">예상치인 2센트</a>에 비해 주당 9센트의 손실로 수익 목표를 달성하지 못했다.
알아두어야 할 사항: 펫코의 소모품 및 서비스 부문은 전년 대비 각각 1.5% 및 3.1% 증가하는 등 성장세를 보였지만 이러한 이익은 공급품 및 반려동물 사업의 4.7% 감소로 상쇄되었다. 이러한 엇갈린 결과에도 불구하고 시장은 긍정적으로 반응하여 화요일 세션 동안 펫코의 주가가 7.72% 상승했으며 츄이는 애완동물 관리 부문의 동종 기업으로서 이러한 모멘텀으로부터 이익을 얻는 것으로 보였다.
펫코의 주가 급등은 예상치 못한 촉매제인 &#8220;로어링 키티(Roaring Kitty)&#8221;로 알려진 키스 길(Keith Gill)의 참여로 인해 수요일까지 계속되었다. 길(Gill)이 레딧(Reddit)에 비밀스러운 메시지를 게시한 후 수요일 정오까지 주가는 거의 35% 급등하여 밈 주식 커뮤니티에 흥분을 불러일으켰다.
추가 사항: 게임스탑 주식의 열광적인 거래와도 관련이 있는 것으로 유명한 &#8216;로어링 키티&#8217;는 키스 길이 이전에 큰 포지션을 보유했던 츄이 주식을 언급한 것으로 추측되는 &#8216;토이 스토리(Toy Story)&#8217;의 비밀스러운 이미지를 게시했다.
CHWY 주가 움직임: 츄이의 주식은 수요일 Benzinga 프로에 따르면, 8.12% 상승하여 30.24달러로 마감되었다. 펫코의 주식은 32.90% 급등한 4.08달러에 마감했다.
<img decoding="async" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/11152300/CHWY-1024x526.png?optimize=medium&amp;dpr=1.25&amp;auto=webp&amp;width=2048" />
Photo via Shutterstock.
다른 트레이더들보다 30분 일찍 독점 시장 움직임 뉴스를 받아보세요 
Benzinga Pro의 14일 무료 체험을 통해 독점 뉴스 기사를 이용할 수 있어 수백만 명의 다른 트레이더보다 먼저 실행 가능한 거래 뉴스를 얻을 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

투자자 라이언 코헨(Ryan Cohen)은 애완동물 용품 및 애완동물 건강 제품의 성장 추세에 맞춰 2011년에 츄이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>)를 설립했다. 새로운 데이터에 따르면 코헨은 애완동물 용품 및 <a href="https://www.benzinga.com/money/pet-insurance-stocks" target="_blank" rel="noopener" data-google-interstitial="false">애완동물 보험</a>에 대한 지출이 크게 증가하는 등 이러한 추세에 초기에 대처했을 수 있었다. 일부는 벌써 그를 전설적인 투자자(GOAT, greatest of all time)들 중 한 명으로 보고 있다.
어떤 일이 (What Happened): 2011년부터 2018년까지 츄이의 <a href="https://www.benzinga.com/news/23/07/33387242/ryan-cohen-mourns-loss-of-his-beloved-poodle-who-inspired-pet-supplies-store-chewy" target="_blank" rel="noopener" data-google-interstitial="false">CEO</a>로 재직한 코헨은 온라인으로 소비자들에게 제공되는 다양한 애완동물 제품과 강력한 고객 서비스 제공에 중점을 두었다.
코헨은 2017년 당시 최대 규모의 전자상거래 인수로 츄이를 펫스마트(PetSmart)에 33억 5천만 달러에 매각했다.
최근 시밀러웹(Similarweb)의 <a href="https://www.similarweb.com/blog/insights/ecommerce-news/pet-health-supplies-trending/">보고서</a>에 따르면 애완동물 용품 카테고리가 지난 12개월 동안 22% 성장한 것으로 나타났기 때문에 이 투자자는 애완동물 부문의 추세를 일찍 알아차렸을 수 있었다.
이러한 추세를 주도하는 데 도움이 되는 것은 대부분의 소비자들이 애완동물을 가족처럼 대하기 때문에 애완동물 건강 제품이다. 이는 그들이 애완동물을 위해 필요한 약이나 음식 옵션에 기꺼이 돈을 지출할 의향이 있음을 의미한다.
시밀러웹은 이러한 추세가 고급 애완동물 스파, 애완동물 전용 호텔, 고급 애완동물 식품 및 건강 보조식품과 같은 프리미엄 카테고리로까지 확산되었다고 말했다.
이 보고서에 따르면 애완동물과 관련하여 개가 선두를 달리고 있으며, 개 카테고리가 전년 대비 24.7% 증가했다. 이 보고서의 애완동물 카테고리에 있는 상위 키워드 중 다수는 개와 관련된 것이다.
이 보고서에 따르면 고양이는 카테고리 관련 매출이 전년 대비 23% 증가하여 크게 뒤처지지 않았다.
다음 읽기: <a href="https://www.benzinga.com/general/entertainment/22/03/26309140/is-ryan-cohen-becoming-the-millennial-generations-warren-buffett" target="_blank" rel="noopener" data-google-interstitial="false">게임스탑의 라이언 코헨이 밀레니얼 세대의 워렌 버핏이 되나요?</a>
왜 중요한가 (Why It&#8217;s Important): 코헨은 애완동물 부문의 현재 추세로부터 이익을 얻지 못할 수도 있지만, 그는 시대를 앞서갔고 업계의 혁명적인 기업가였을 가능성이 높다. 그는 특정 제품에 초점을 맞추고 애완동물 소유자들이 애완동물 사료, 용품, 건강 제품을 집까지 배송받을 수 있도록 함으로써 해당 부문의 성장을 위한 기반을 마련했다.
애완동물 부문 성장으로 이익을 얻을 수 있는 투자자 중 한 명은 <a href="https://www.benzinga.com/news/24/07/39601962/whats-going-on-with-chewy-stock-today" target="_blank" rel="noopener" data-google-interstitial="false">츄이의 투자자</a>인 로어링 키티(Roaring Kitty)의 별명으로 잘 알려진 키스 길(Keith Gill)이다. 이 유명한 밈 주식 투자자인 그는 코헨이 CEO로 있는 비디오 게임 소매업체 게임스탑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>)의 과거 투자자로서 코헨을 굳게 믿었다.
애완동물 부문이 성장하면서 츄이가 승자로 돋보일 수 있지만, 전자상거래, 애완동물 보험 등과 같은 분야를 포괄하여 향후 몇 년 동안 이익을 얻을 수 있는 다른 애완동물 관련 주식들도 있다.
<ul>
<li>프레시펫 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>)</li>
<li>트루패니언 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>)</li>
<li>바크 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BARK#NYSE">BARK</a>)</li>
<li>펫코 헬스 앤드 웰니스컴퍼니 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)</li>
<li>레모네이드 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>)</li>
<li>펫메드 익스프레스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>)</li>
</ul>
Photo: Courtesy of Bill Jerome on Flickr
Benzinga Pro의 독점 뉴스 및 도구로 더 많은 승리를 거두세요 
독점 속보 및 스캐너와 같은 Benzinga Pro의 강력한 도구 세트로 다른 트레이더보다 우위를 점하세요. 
<a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor" target="_blank" rel="noreferrer noopener">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

펫코 헬스 앤 웰니스 컴퍼니(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)의 주가는 이전의 트위터인 <a href="https://www.benzinga.com/pressreleases/24/06/n39499501/petco-releases-2023-esg-report-announces-large-scale-recycling-program-to-divert-ldpe-plastic-from" target="_blank" rel="noopener" data-google-interstitial="false">X에 개 사진을 게시</a>한 로어링 키티(Roaring Kitty)로 알려진 키스 길(Keith Gill)의 소셜 미디어 게시물 이후 금요일 급등했다.
무슨 일이 (What's Happening): 2021년 게임스탑의 숏스퀴즈(공매도 압박) 역할로 유명한 로어링 키티의 소셜 미디어 게시물이 반려동물 관련 주식에 대한 관심을 급증시켰다. 길이 과거에 상당한 이익을 얻을 가능성이 있는 주식을 식별하고 홍보하는 데 성공했다는 점을 고려하면 주식 시장에서 길의 영향력은 상당하다.
또 다른 사항 (What Else): 또한 펫코는 최근 주요 이니셔티브와 성과를 강조하는 2023년 환경, 사회 및 거버넌스(ESG) 보고서도 발표했다. 이 보고서에는 매립지에서 저밀도 폴리에틸렌(LDPE) 플라스틱을 전환하는 것을 목표로 하는 새로운 대규모 재활용 프로그램이 자세히 설명되어 있으며, 매년 약 150톤의 플라스틱을 재활용할 것으로 예상된다.
이 보고서는 또한 약 143,000마리의 애완동물을 위한 집을 찾고 자원이 부족한 지역 사회의 애완동물에게 220만 개 이상의 무료 백신을 제공하려는 펫코 러브(Petco Love)의 노력을 강조한다.
WOOF 주가 움직임: 펫코의 주식은 <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro</a>에 따르면 금요일 13.17% 상승한 3.78달러에 마감했다. 이 후 시간외 거래에서 3.73% 추가 상승했다.
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" class="wp-image-411772" style="width: 523px; height: auto;" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/28145638/WOOF-1024x540.png" sizes="(max-width: 1024px) 100vw, 1024px" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/28145638/WOOF-1024x540.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/28145638/WOOF-300x158.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/28145638/WOOF-768x405.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/06/28145638/WOOF.png 1080w" alt="" width="1024" height="540" /></figure>
이미지 소재: 셔터스톡.

애완동물 소매업체 펫코 헬스 주식이 금요일 급등한 이유?

&#8216;로어링 키티(Roaring Kitty)&#8217;로 알려진 키스 길(Keith Gill)이 이전에 트위터로 알려진 X에 개 만화 <a href="https://x.com/TheRoaringKitty/status/1806371920495186041">이미지</a>를 게시한 후 목요일에 대부분의 애완동물 관련 주식이 일시적으로 상당한 상승세를 보였다. 그러나 시장 마감 직전 대부분이 이 날의 상승 일부 또는 전부 반납하는 큰 변동성을 보였다.
현황 (What's Happening): 길의 트윗에는 개를 그린 단순한 만화 이미지가 등장했지만, 여러 기업들의 주가가 급등하기에는 충분했다. 주목할 만한 주식 중에는 장 중 잠시 주가가 약 10% 상승한 츄이(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHWY#NYSE">CHWY</a>), 4% 상승한 펫메드 익스프레스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETS#NASDAQ">PETS</a>) 그리고 펫코 헬스 앤 웰니스 컴퍼니(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WOOF#NASDAQ">WOOF</a>)도 4% 상승했다.
기타 주요 소식들 (What Else): 로어링 키티라는 가명으로 키스 길은 게임스탑에 대한 초기의 낙관적인 입장으로 명성을 얻었으며 이를 레딧 및 유튜브와 같은 플랫폼들에서 공유했다. 그의 분석과 열정은 2021년 초 대규모 숏스퀴즈를 촉진하는 데 도움이 되었으며, 이는 게임스탑(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>)의 천문학적 이익으로 이어졌고 주식 시장에서 소매 투자자들과 소셜 미디어의 영향력에 대한 관심을 불러일으켰다.
길은 2021년 게임스탑 공매도에서 자신의 역할로 유명하다. 이는 전통적인 금융 지표가 아닌 소셜 미디어와 온라인 포럼을 통해 인기를 얻는 주식인 &#8220;밈 주식&#8221;이 부상하는 중추적인 순간이었다.
CHWY, PETS 및 WOOF 주가 움직임:
<ul>
<li>츄이의 주가는 장 후반에 초반 상을 반납하고 0.31% 하락한 29.05달러에 마감했다. 이후 시간외 거래에서 1.24% 추가 하락했다.</li>
<li>펫메드의 주가는 장 후반 일부 상승을 반납하였지만 여전히 2.96% 상승한 4.18달러에 마감했다.</li>
<li>펫코의 주가도 장 후반 일부 수익을 반납하고 0.30% 오른 3.34달러에 마감했다. 이후 시간외 거래에서 6.29% 급등하였다.</li>
</ul>
관련 기사: <a href="https://www.benzinga.com/news/24/06/39525132/2024-sees-record-number-of-new-etfs-driven-by-active-fund-managers-report">2024년에는 액티브 펀드 매니저들이 주도하는 신규 ETF의 기록적인 수가 기록될 것: 보도</a>
Photo via Pixabay.

Comments

Petco Health and Wellness

뉴스

에 대한 최신 뉴스 Petco Health and Wellness (NASDAQ:WOOF) 주식

일요일, 9월 15, 2024

수요일, 9월 11, 2024

토요일, 7월 13, 2024

토요일, 6월 29, 2024

금요일, 6월 28, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌